Funding for this research was provided by:
National Cancer Institute (T32CA113951, 5P30CA016056-42, 5P30CA016056-42, 5P30CA016056-42, 5P30CA016056-42, 5P30CA016056-42)
Received: 31 January 2022
Accepted: 7 June 2022
First Online: 22 June 2022
: Institutional Review Board Statement: The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Institutional Review Board (or Ethics Committee) of Roswell Park Comprehensive Cancer Center (EDR-103707 2/28/2018 l). Informed Consent Statement: A waiver of consent was obtained from the Institutional Review Board of Roswell Park Comprehensive Cancer Center due to the retrospective nature of the study making consent impractical and contacting patients to obtain consent would pose a greater risk than the waiver.
: Not applicable.
: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.